Latest Advances in R&D on LNPs for RNA Drug Delivery
Hybride workshop
course number: 7052
- Drug Delivery
- Hot Topics
- Research and Development
Workshop program / Flyer
- 7052_LNPs.pdf (1 MB)
Date and venue
Start:
2025-05-06, 14:30
End:
2025-05-07, 13:30
Add appointment to calendar
Venue
INVITE GmbH
Otto-Bayer-Str. 32
51061 Köln
Germany
Summary
Organizing committee
■■ Prof. Gert Storm, Utrecht University, NL and National
University of Singapore, SG
■■ Dr. Andrea Engel, Evonik Health Care, Birmingham,
Alabama. US
■■ Dr. Simon Geissler, Merck Healthcare, Darmstadt, DE
■■ Dr. Peter van Hoogevest, Pharmanovation Consulting,
Rheinfelden (Baden), DE
Target group
The course is intended for all scientists involved in the research, development
and manufacture of Lipid Nano Particles (LNPs).
Objective
LNPs (Lipid Nanoparticles) have revolutionized the targeted
delivery of nucleic acid. Following their groundbreaking
role in COVID-19 vaccinations and hepatocyte-targeted
therapies (Onpattro®) as current product examples, the
field of LNPs is poised for further exploration. Academic
and industrial R&D are now facing the challenge to
further profit from and elaborate this breakthrough and
find new applications for the LNP technology. The course
addresses the latest progress made in the preclinical and
clinical R&D on these nanoparticles, including production,
stability, analytical and in-vivo delivery strategies. In addition,
the course informs on the increase of understanding of
the relation between LNP structure/composition and PK,
tissue distribution, efficacy and toxicity. Top experts in
this field from leading academic institutes and industry
will review these aspects in detail, share their knowledge
and findings, and provide a comprehensive overview of the
state-of-the-art and prospects in LNP research.
Organizer(s)
Kurfürstenstraße 59
55118 Mainz
Germany
Dr. Martin Bornhöft
Phone: +49 6131 9769-0
E-mail: info@apv-mainz.de
https://www.apv-mainz.de
Prices
All prices free of VAT